| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
*
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140; and
Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany
Current address: Ben May Institute for Cancer Research, University
of Chicago, Chicago, IL 60637.
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and IL-2 and induces a cell-mediated immune response to Ag, whereas the
Th2 subset produces IL-4, IL-5, and IL-10 and is necessary for
generating a humoral immune response against Ag. The biological
relevance of these two subsets in infection is underscored by the
ability of Th1 and Th2 cells to influence disease outcome
(4). For example, protection against most intracellular
pathogens requires cell-mediated immune responses generated by Th1
cells, whereas biasing of the host immune response toward a Th2 type
promotes humoral immunity, resulting in disease. Although the impact on disease of a restricted cytokine production pattern is well established, a clear understanding of the mechanisms leading to dominance of a particular T cell subset in disease is just emerging (5). Understanding both the factors that modulate the decision of a naive CD4+ T cell to develop into a Th1 or Th2 cell in response to an Ag and the mechanisms regulating responsiveness to Ag of differentiated subsets may lead to rational approaches for generating appropriate immune responses to a pathogen. Ag dose (6), APCs (7, 8) with their associated costimulatory signals (9, 10) and cytokines (11, 12) all have varying effects on the differentiation of T cells and the final outcome of a disease state. Emerging evidence suggests that the Fas/Fas ligand (FasL)3 apoptotic pathway, required for maintenance of T cell homeostasis and self tolerance (13), in addition, may also contribute to certain disease states through preferential induction of Th1 cell apoptosis (14, 15, 16).
Fas (APO-1, CD95) receptor is a cell death receptor that is activated by FasL, a trimeric transmembrane protein (17). Receptor oligomerization results in the recruitment of the death domain protein FADD to the FasR (18, 19, 20, 21, 22), followed by the IL-1ß-converting enzyme (ICE)-like protease, caspase-8, to form a functional death-inducing signaling complex (DISC) (23). Upon triggering of the FasR, caspase-8 bound to the DISC gets proteolytically cleaved to generate two active fragments (24). The active fragments are released into the cytosol where they initiate activation of a cascade of ICE-like proteases (25) and subsequent death. Following recruitment to the DISC, active caspase-8 that is generated can directly mediate activation of caspase-3 and other downstream caspases, leading to apoptosis (26). Alternatively, in some cell types, active caspase-8 cleaves BH3-interacting domain death agonist (Bid), which then acts on mitochondria to release cytochrome c. Cytochrome c, in association with Apaf-1 and procaspase-9, activates caspase-3 and other downstream caspases (26, 27).
There are two other pathways that may also be engaged following FasR ligation. Recruitment of an adaptor molecule Daxx to the receptor activates a c-Jun amino-terminal kinase (JNK) pathway that leads to gene transcription and subsequent death (28, 29). FasR ligation also catalyzes the hydrolysis of membrane sphingomyelin, which results in a rapid increase in endogenous levels of ceramides (30, 31, 32), which in turn can either directly activate caspases or intersect with a ras-dependent death pathway. Recent studies utilizing FADD (33), caspase-8, (34), caspase-9 (35, 36), and acid sphingomyelinase-knockout mice (37), however, indicate that the FADD/caspase-8 signaling pathway is central and probably nonredundant in inducing death by the FasR. Therefore, the role of other pathways in FasR signaling, besides FADD/caspase-8, remain debatable.
Previously, we demonstrated that mature Th1 and Th2 cells can be differentially regulated to undergo Fas-mediated apoptosis upon CD3 ligation (14), implying that this form of apoptosis may play a significant role in suppressing Th1 cells. We showed that activated Th1 cells are susceptible to Fas-mediated apoptosis upon CD3 ligation. In contrast, prior activation through CD3 of Th2 cells induced resistance to Fas-mediated apoptosis. However, direct ligation of the FasR induced apoptosis of both Th1- and Th2-type cells. Thus, differences in sensitivity to apoptosis of Th1 and Th2 cells is not due to an intrinsic defect in the Fas signal transduction pathway in Th2 cells, as reported by others (16, 38, 39), but due to interception of this pathway from signals generated through CD3.
In view of the role that apoptosis may play in the loss of Th1-dependent effector functions in disease, it becomes necessary to establish the molecular mechanisms controlling T cell subset-specific apoptosis. In this work, we therefore investigate the mechanism of differential susceptibility to apoptosis of Th1 and Th2 cells and examine CD3-generated signals that regulate this apoptotic pathway. We report that the difference in Fas sensitivity of CD3-activated Th1 and Th2 cells is not at the level of recruitment of caspase-8 to the DISC, but at the level of caspase-8 cleavage to its active fragments. We identify phosphatidylinositol 3'-kinase (PI3'-K) as the key signaling molecule generated through CD3 engagement on Th2 cells that regulates the resistance to Fas-induced apoptosis by preventing caspase-8 cleavage to its active fragments. These findings describe a novel mechanism that T cells utilize to resist FasR-induced apoptosis. It also provides the first evidence that PI3'-K interferes with caspase-8 activation.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Tetanus-toxoid and purified protein derivative-reactive clones
were established by limiting dilution technique, as previously
described (3). Cytokine profile was determined by
stimulating cells with plate-bound anti-CD3 Abs and by testing 24-h
supernatants for the presence of TNF-
, IFN-, and IL-4 by ELISA.
To expand cell numbers, clones were maintained in IL-2, with biweekly
stimulation of Ag and autologous APCs. Cytokine profile of the clones
was routinely reconfirmed after several rounds of stimulation. We have
observed that, even after several passages in vitro, the cytokine
profile and Ag reactivity are unchanged. As previously described, Th1
and Th0 type 1 clones undergo apoptosis when anti-CD3 stimulated;
for sake of clarity, herein Th1 and Th0 type 1 clones will be referred
to as apoptosis-susceptible clones. Conversely, Th2 and Th0 type 2
clones will be referred to as apoptosis-resistant clones. A total of
nine individual T cell clones of both the apoptosis-susceptible (CG2,
JC2, HG17, and PS13) and -resistant (HG3, HG5, HG6, HG10, and SPU)
phenotype were included in this study.
Abs and reagents
Anti-CD3 mAb was obtained from Biosource International
(Camarillo, CA). The anti-APO-1 mAb (IgG3,
) is an agonistic Ab
recognizing an extracellular epitope of CD95 (40). The
three anti-caspase-8 Abs utilized recognize the three functional
domains of caspase-8. N2 recognizes an epitope adjoining the tandem
death effector domain containing pro-domain. C15 detects the
catalytically active p18 fragment, and C5 binds to an epitope within
the p10 fragment (41). The NF6 anti-cellular
FLICE-inhibiting protein (c-FLIP) mAb (IgG1) recognizes the N-terminal
part of human c-FLIP (42). IETD-fmk is a cell permeable
caspase-8-specific inhibitor (Clontech, Palo Alto, CA) and was used at
25 µM. Wild-type (WT) and dominant-negative phosphatidylinositol
3'-kinase p85 regulatory subunit containing plasmids (43)
were provided by Tomas Mustlin (La Jolla Institute of Allergy and
Immunology, San Diego, CA). Successfully transfected T cells were
selected on the basis of their expression of a murine MHC class I
molecule encoded by the cotransfected plasmid, pMACS Kk (Miltenyi
Biotec, Gladbach, Germany). Wortmannin was purchased from Sigma (St.
Louis, MO).
Apoptosis detection
Apoptosis of cells was determined using a sandwich ELISA (44). The ELISA relies on the detection of cytoplasmic nucleosomal fragments released from the nucleus during the apoptotic process. To obtain cytoplasmic nucleosomes, cells were lysed in ice cold buffer (1% Nonidet P-40, 20 mM EDTA, 50 mM Tris-HCl (pH 7.5)), for 0.5 h, in a volume sufficient for a final concentration of 1.25 x 105 cell equivalents/ml. Nuclei were pelleted by centrifugation at 13,000 x g for 10 min, following which the supernatant was carefully removed and used for analysis. Lysates from 5 x 103 cell equivalents were added to each well, with each sample tested in triplicate. Nucleosomal fragments were captured with an anti-histone mAb (LG11-2A) and detected with a biotinylated secondary mAb (PL2-3) that recognizes a DNA-histone complex. Bound Ab/Ag complexes were then reacted with alkaline phosphatase-conjugated streptavidin (Southern Biotechnology, Birmingham, AL), to which substrate was then added. Color development was measured at 405 nm. The percentage of apoptosis is expressed in arbitrary units, calculated as follows using cells maintained in IL-2 as control: 100 - [(absorbance values at OD405 of IL-2 culture/absorbance value at OD405 of treated cells) x 100].
DISC analysis and Western blotting
Association of caspase-8 with the DISC of unactivated and CD3-activated apoptosis-resistant and -susceptible clones was determined after directly ligating FasR. T cells (107) of the resistant and susceptible clone were either treated with CD3 Abs for 30 min or left untreated, following which the cells received 500 ng/ml anti-APO-1 Abs for 5 min at 37°C. Control cells were stimulated with anti-CD3 Abs alone; however, the lysates of these cells received anti-APO-1 Abs. Cells were harvested, washed in cold buffer, pelleted, and lysed in ice cold lysis buffer (30 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF, and small peptide inhibitors, as described in Ref. 45 , for 30 min. Cell debris was pelleted by centrifugation for 10 min at 13,000 x g. To the lysates, 50 µl of rabbit anti-mouse (Cappel, Cochranville, PA)-coated staphylococcus A was added. DISCs were allowed to immunoprecipitate in the cold for at least 1 h, then were washed in cold TNE buffer. After washing 6x, immune complexes and staphylococcus A were separated by 15 min incubation in 2-ME containing sample buffer, staphylococcus A was spun out, and the supernatants containing the immunoprecipitates were boiled. For Western blotting, lysates were separated on 12% SDS-PAGE, transferred to supported nitrocellulose membrane (Bio-Rad, Hercules, CA), and blocked with nonfat milk-containing TTBS. Blots were incubated with primary Ab diluted in TTBS overnight at 4°C, washed 3 to 4 times for 10 min each with TTBS, then detected with HRP-conjugated secondary Ab diluted 1:3000 in TTBS + 5% nonfat milk, and developed using the enhanced chemiluminescence method (ECL Plus, Amersham, Arlington Heights, IL) following the manufacturer’s protocol.
Transient transfection and positive selection of transfected T cell clones
Cells (10 x 106) of an apoptosis-resistant clone (SPU) were suspended in 250 µl serum free RPMI 1640 (Mediatech, Herndon, VA), and transferred to an electroporation cuvette specific for eukaryotic cells (Bio-Rad Gene Pulser Cuvette, 0.4-cm electrode, gap 50). To the cuvette, 20 µg total plasmid DNA was added, with the p85WT or p85 MUT DNA in a 1:1 ratio with the cotransfected pMAX plasmid, and allowed to incubate for 10 min at room temperature. Electroporation was conducted at 250 V, 960 µF. Immediately after electroporation, cells were placed at 37°C for 10 min, then cultured in IMDM (Life Technologies, Grand Island, NY) supplemented with 10% AB serum (BioReclamation, Long Island, NY) and 20 U/ml IL-2 (National Cancer Institute, Frederick, MD). Following 72 h incubation, dead cells were removed by separation using Ficoll-Paque (Pharmacia, Uppsala, Sweden) density gradient centrifugation, with the remaining cells resuspended in PBS + 0.5% BSA. To magnetically label the suspension, MACSelect Kk microbeads were added and allowed to bind the T cells at 4°C for 15 min, following which volume was adjusted with PBS, and the cells were applied to the magnetic selection column. Cells not expressing the murine class I molecule were not retained in the column, while transfectants were eluted and collected by removing the column from the magnetic field and flushing the column with additional buffer. Recovery of cells after positive selection was 2% of the input number.
PI3'-K activity
The activity of immunoprecipitated PI3'-K was determined by the phosphorylation of the substrate phosphatidylinositol to phosphatidylinositol 3-phosphate with and without a 10-min anti-CD3 stimulation. Lipid substrate was chloroform extracted from the kinase reaction buffer, then separated by TLC and analyzed by autoradiography. Quantitative assessment of kinase activity was obtained using phosphorimaging (30).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Our previous data demonstrated that, upon CD3 stimulation, Th1
cells undergo Fas-mediated apoptosis. In contrast, Th2 cells do not
undergo apoptosis upon CD3 stimulation (14). We also
showed that Th0 cells consist of two subsets, one that behaves like Th1
cells and undergoes Fas-mediated apoptosis following CD3 stimulation
(Th0 type 1), and the other subset is similar to Th2 cells and is
resistant to apoptosis (Th0 type 2). Paradoxically, all clones were
susceptible to apoptosis when Fas receptor was directly ligated by
anti-Fas Abs. However, prior activation of Th2 and Th0 type 2
clones by mAbs to CD3/TCR complex induced resistance against
Fas-mediated apoptosis (14). In Table I
, we have listed the sensitivity to both
CD3 and direct FasR ligation-mediated apoptosis of the clones utilized
in the present study. As shown in Table I, and as previously reported
(14), clones susceptible to CD3-mediated apoptosis are Th1
and Th0 type 1, and clones resistant to CD3 stimulation are Th2 and Th0
type 2. Studies described in this article are designed to provide a
mechanism for our previous observation that anti-CD3 rapidly
protects Th2 cells from death caused by direct FasR ligation with
agonistic Abs (14).
|
To determine whether the FADD/caspase-8 pathway is being
differentially regulated in the Th1 and Th2 clones, we utilized the
inhibitor IETD-fmk, which interrupts the FADD/caspase-8 apoptotic
pathway by functioning as a noncleavable substrate for active caspase-8
(20). CD3 ligation induces apoptosis in all three
susceptible clones (Fig. 1). However,
addition of IETD-fmk during CD3-activation fully protects these cells
from Fas-mediated death (Fig. 1). We therefore further investigated the
FADD/caspase-8-associated death pathway used in activated Th1- and
Th2-type cells.
|
Recently, a caspase-8-like protein without enzymatic activity,
c-FLIP, was cloned (46). In stable transfectants, c-FLIP
was shown to interfere with the activation of caspase-8 at the DISC
(42). Thus, we wished to determine whether preferential
recruitment of c-FLIP to the DISC in Th2-type cells could be
responsible for its resistance to Fas. An apoptosis-resistant and an
apoptosis-susceptible clone were treated with anti-CD3 Abs for 30
min before ligating their Fas receptors with anti-APO-1 Abs. FasR
was immunoprecipitated, and the DISCs were Western blotted and probed
with anti-c-FLIP Abs. As shown in Fig. 2, in anti-CD3-treated cells of both
resistant (lane 1) and susceptible clones
(lane 4), no recruitment of c-FLIP to the
nonactivated Fas receptor is observed. However, detectable c-FLIP
recruitment to the DISC is observed in both apoptosis-resistant and
-susceptible clones, with (lanes 3 and 6)
or without (lanes 2 and 4) prior CD3
treatment. This suggests that additional regulatory mechanisms, such as
an improper DISC assembly or inappropriate caspase-8 cleavage at the
DISC, are conferring Th2 resistance to Fas-induced apoptosis. Thus, we
next tested the ability of Th2 cells to recruit and process
caspase-8.
|
Caspase-8, as with all known caspases, exists in the cytoplasm in
a pro-form (20). Previous studies have described that, on
triggering of the FasR, caspase-8 gets recruited to the DISC where it
is proteolytically activated (24). Initial cleavage of
DISC-associated caspase-8 generates a p43 and a p12 fragment. The
latter gets further processed to a p10 fragment. Subsequently, the
DISC-associated p43 gets cleaved to release the active site-containing
fragment p18 from the prodomain p26 (24) (Fig. 3, A and B). We
therefore examined by immunoprecipitation and Western blotting the
DISCs of Th1 and Th2 cells activated under different conditions. FasR
on a susceptible (JC-2) clone and a resistant (SP-U) clone was directly
ligated with anti-APO-1 (anti-Fas) Abs for 5 min, with or
without prior stimulation with anti-CD3 Abs. FasR was
immunoprecipitated, separated on 12% SDS-PAGE gel, and probed with
anti-caspase-8 Ab C15, which recognizes full-length caspase-8, and
the first cleavage intermediate of caspase-8, the p43/41 fragment (Fig. 3, A and B). As seen in Fig. 3C,
56-kDa pro-caspase-8 is associated with the FasR under conditions where
the cells are undergoing apoptosis (APO-1 Abs alone, lane 2)
and also under conditions where the cells are resistant to apoptosis
(anti-CD3 + anti-APO-1 Abs, lane 3). A 43-kDa band
indicative of the first cleavage fragment of caspase-8 is also observed
in the resistant clone (Fig. 3C, lanes 2 and
3), suggesting that cleavage has been initiated at the DISC
of the apoptosis-resistant clone. In the susceptible JC-2 clone, as
expected, both in the presence of anti-APO-1 Abs alone
(lane 5) and in the presence of anti-APO-1 +
anti-CD3 Abs (lane 6), caspase-8 is recruited to
the DISC, and the presence of p43/41 is observed (Fig. 3C,
lanes 5 and 6). Both apoptosis-resistant and
-susceptible clones stimulated with CD3 Abs alone do not demonstrate
any caspase-8 recruitment (Fig. 3C, lanes 1 and
4).
|
D, the blot was reprobed with the N2 Ab, which
recognizes p26 fragment of caspase-8, (Fig. 3, A and
B). As observed previously with C15 Ab, p43/41 is found in
the resistant clone, both under apoptosing and nonapoptosing
conditions. p26, the cleavage product of p43/41, is observed in the
resistant clone when treated with anti-APO-1 Abs (Fig. 3D, lane 2). However, when cells are stimulated
with anti-CD3 Abs before addition of anti-APO-1 Abs, conditions
that protect these cells from apoptosis, no p26 is detected (Fig. 3D, lane 3). In the susceptible clone, again as
expected, p26 was observed both when cells are treated with
anti-APO-1 Abs (Fig. 3D, lane 5) and also
when pretreated with CD3 before addition of anti-APO-1 Abs (Fig. 3D, lane 6). In lane 4 of Fig. 3D, the susceptible clones do not show any caspase-8
recruitment, since they are treated with CD3 for only 30 min, which is
insufficient length of time to induce endogenous FasL. However, 30 min
of CD3 engagement is sufficient to generate protective signals in
resistant clones. Generation of catalytically active caspase-8 fragments is arrested in Th2 clones
Lysates from Th1 and Th2 clones were further probed with C15 and
C5 Abs (Fig. 3, E and F) to analyze caspase-8 cleavage
products released from the DISC into the cytosol. C15 Ab detects the
p18 fragment, and C5 Ab detects the p10 fragment (Fig. 3A).
The presence of active site-containing p18 (Fig. 3E) and p10
(Fig. 3F) fragments is observed only in the
apoptosis-sensitive clones (lanes 5 and
6). The presence of the p12 fragment, a cleavage
intermediate of full length caspase-8 (p56 cleavage giving rise to p43
and p12 products), suggests that caspase-8 cleavage is initiated in
both the resistant and susceptible clones. However, further processing
of p12 to the active p10 fragment and cleavage of p43 to p26 and the
active p18 fragment do not occur in the resistant Th2 clone (Fig. 3, E and F). This cleavage process is being
specifically prevented in the Th2 clone by signals generated upon CD3
ligation.
PI3'-K inhibitor sensitizes activated Th2 cells to Fas-mediated death
The immunoprecipitation and Western blot results indicate that Th2
cells utilize a novel strategy to protect themselves from Fas-mediated
death, by actively disrupting the DISC. Since this protection was only
obvious after CD3 ligation, it was important to uncover which signals
generated by CD3 intersected with the FADD/caspase-8 pathway. Keeping
in mind that PI3'-K protects from apoptosis in other systems, we used
wortmannin, an inhibitor of PI3'-K, and examined induction of apoptosis
in five individual Th2 clones. As previously observed, anti-APO-1
(Fas) Abs induce apoptosis of Th2 cells that can be abrogated if the
cells are stimulated with CD3 Abs before FasR ligation. However, CD3
stimulation of wortmannin-treated cells followed by FasR ligation leads
to a dramatic increase in apoptosis of the normally resistant Th2
clones (Fig. 4A). Pretreatment
of Th2 clones with wortmannin before CD3 stimulation does not induce
death in the T cell clones, confirming that the wortmannin is not toxic
to the cells.
|
The wortmannin results suggest that, upon CD3 stimulation, PI3'-K
becomes active and, acting on downstream substrates, is able to
interfere with an orderly apoptotic cascade. To further confirm the
role of PI3'-K in preventing Fas-mediated apoptosis, WT and a dominant
negative mutant of the p85 regulatory subunit of PI3'-K were
transiently transfected into a typical apoptosis-resistant Th2-type
clone (SPU). Successful transfectants were selected on the basis of
their expression of a murine MHC class I molecule, which had
been cotransfected with the p85 subunit encoding plasmid. Following
8 h of CD3 stimulation, cells were harvested and prepared for
apoptosis ELISA. Cells receiving the WT p85 behaved as normal
untransfected counterparts, i.e., resistant to Fas-mediated death (Fig. 4B). However, the cells transfected with the
dominant-negative mutant become susceptible to apoptosis (Fig. 4B).
Differential ability of Th1 and Th2 cells to activate PI3'-K
Pharmacological and gene transfer experiments imply that the
apoptosis-resistant and -susceptible clones differ in their ability to
activate PI3'-K. To explore this possibility, we compared the activity
of PI3'-K in four resistant and four susceptible clones, before and
after CD3 ligation. T cell clones were rested for 8 h in the
absence of IL-2 (this length of time does not affect the viability of
the cells) to reduce background PI3'-K activity. Cells (5 x
106) each were stimulated with anti-CD3 Abs,
or the same number of cells was left untreated. Cell lysates were
prepared and subjected to immunoprecipitation with Abs to the p85
regulatory subunit of PI3'-K. Kinase activity was measured using
[-32P]ATP and phosphatidylinositol (PI) as
the substrate. Radiolabeled lipids were separated by TLC and
quantitated by phosphorimaging. Radiolabeled lipids were identified by
comparison of rf to known standards (Fig. 5). The four resistant clones SPU, HG3,
HG5, and HG15 exhibited percentage increases in kinase activity of 156,
1000, 285, and 251%, respectively. In contrast, the susceptible clones
had significantly lower activity. PS13, 59.5, JC6, and JC1 exhibited
percentage increases of kinase activity of only 79, 41, 26, and 16%,
respectively (Fig. 5).
|
To test how PI3'-K was regulating apoptosis in Th2 cells, we next
determined whether blockade of PI3'-K permitted the generation of
active caspase-8 fragments. We tested caspase-8 cleavage pattern in an
apoptosis-resistant Th2-type clone (SPU) that was stimulated with
anti-CD3 Abs in the presence or absence of wortmannin, followed by
FasR ligation. FasR was immunoprecipitated, separated on 12% SDS-PAGE
gel, and probed with the anti-caspase-8 Ab C15, which recognizes
full-length caspase-8, and the first cleavage intermediate of
caspase-8, the p43/41 fragment. Both full-length p56 caspase-8 and
partially cleaved p43/p41 are detected with C15 Abs when cells are
treated with anti-APO-1 alone (Fig. 6A, lane 3), Abs to
APO-1 and CD3 (Fig. 6A, lane 4), or Abs to APO-1
and CD3 in the presence of wortmannin (Fig. 6A, lane
5). C15 Abs were also used to probe the lysates for the presence
of p18. Ligation of FasR alone leads to the generation of the
catalytically active p18 in the resistant clone (Fig. 6B,
lane 3), which can be blocked by CD3 stimulation (Fig. 6B, lane 4). However, in the presence of
wortmannin, complete cleavage of caspase-8 to p18 fragment is observed
(Fig. 6B, lane 5). These results demonstrate that
inhibiting PI3'-K allows complete cleavage of caspase-8, which is
inhibited in CD3-activated Th2 cells that resist apoptosis.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The search for mechanisms that permit T cells to resist apoptosis has led to the discovery of a number of molecules that block the FADD/caspase-8 apoptotic pathway (46, 47, 48). Previous work indicates that bringing caspase-8 into close proximity with another caspase molecule at the DISC is sufficient to permit autoproteolysis of the caspase to occur (24). Therefore, the most efficient way to inhibit the FADD/caspase-8 apoptotic pathway is to prevent recruitment of caspase-8, resulting in a nonfunctional DISC. Indeed, recently such a protein, termed c-FLIP, has been cloned (46) that can compete with caspase-8 for binding to FADD, and thereby blocking recruitment of caspase-8 to the DISC (42). That this strategy may be utilized by cells that undergo IL-2-dependent Fas-mediated apoptosis has been suggested (49). However, recent studies examining the inability of short-term activated peripheral T cells to recruit caspase-8 (45) indicates that c-FLIP is not involved in preventing caspase-8 recruitment to the DISC, unless it is overexpressed (42). The present data also support this finding by showing that resistance of Th2 cells is not at the level of c-FLIP. The amount of endogenous c-FLIP present in T cells is insufficient to prevent caspase-8 recruitment and apoptosis induction (present data and Ref. 42). c-FLIP, only when overexpressed, can compete with caspase-8 for binding to FADD, and thereby halt caspase-8 recruitment and activation.
Our results demonstrate that the differences in caspase-8 processing at the DISC of Th1 and Th2 cells is due to differential PI3'-K activation in the two subsets following CD3 stimulation. PI3'-K has been shown previously to protect cells from a variety of apoptotic stimuli (50, 51, 52, 53). More recently, it has been clearly demonstrated that serine threonine kinase AKT/protein kinase B, a target of PI3'-K, is an essential signaling intermediate in this antiapoptotic pathway. AKT can catalyze BAD phosphorylation and thereby sequester it from bcl-xL/bcl-2, thus preventing apoptosis (51, 54). AKT can also phosphorylate caspase-9 and prevent it from activating caspase-3 (66). Both these targets of AKT are components of the mitochondrial-dependent pathway of Fas-mediated apoptosis. This pathway is characteristic of cells that recruit low amounts of caspase-8 to the DISC and are therefore not efficient at directly activating caspase-3 (26). In contrast, cells that recruit large amounts of caspase-8 to the DISC can directly activate caspase-3 and bypass the mitochondria. These cells therefore may have developed other PI3'-K/AKT targets whose phosphorylation would abrogate apoptosis. Cells described in these studies recruit large amounts of caspase-8 to the DISC and thus provide a model system to address in the future how PI3'-K directly or through AKT regulates caspase-8 cleavage and subsequent caspase-3 activation in the mitochondrial-independent pathway of Fas signaling.
Engagement of the TCR/CD3 complex initiates the activation of a number of protein tyrosine kinases, followed by recruitment and activation of ZAP-70 (55, 56). One of the key substrates for ZAP-70 is linker for activation of T cells (LAT). Phosphorylated LAT associates with the p85 subunit of PI3'-K directly and also via tyrosine phosphorylated cbl (57). TCR-interacting molecule (TRIM) (58) is another linker protein containing several tyrosine-based signaling motifs that, upon phosphorylation, can also associate with p85 (59). Thus, both TRIM and LAT function as linker molecules to target PI3'-K to the membrane where it can potentially interact with its lipid substrates and other activators, such as Ras (60, 61). The data reported here reveal that Th1 and Th2 cells regulate PI3'-K activation differently upon CD3 activation leading to differences in their ability to resist Fas-mediated apoptosis. Future studies will include a systematic comparative analysis of CD3 signaling in the two subsets to gain a better insight into the mechanisms of why CD3 signaling in Th1 cells results in poor activation of PI3'-K. Indeed, previous studies have indicated that Th1 and Th2 cells signal differently upon engagement of their TCRs. Fitch and colleagues studying murine Th1 and Th2 clones have shown that stimulation of Th1, but not Th2, clones with anti-TCR Abs leads to elevated [Ca2+] (9, 62). Similar observations were made in another study where calcium ion signaling was measured in T cells as they differentiated from naive T cells to mature Th1 and Th2 effector populations (63). Naive T cells engaged the Ca2+ pathway, which was further enhanced if the cells were biased to differentiate into Th1 cells. In contrast, under Th2-differentiating conditions, the naive T cells selectively lost their ability to use this signaling pathway. PKC-dependent signaling leading to preferential up-regulation of FasL and subsequent susceptibility to apoptosis occurring only in Th1 cells, is yet another instance of differences between Th1 and Th2 cells in CD3 signaling (39). Thus, distinct signaling pathways are activated in Th1 and Th2 cells upon ligation of their CD3/TCR that can lead to differences in their effector functions and activities.
The biological significance of the differential susceptibility of Th1 and Th2 cells to undergo apoptosis when activated in the absence of costimulation become important during receptor triggering in response to Ag. During Ag presentation, and in a milieu that provides T cells with necessary costimulatory signals, Th1 cells will be capable of proliferating, and thus activating cellular immune responses. However, if an intracellular pathogen has disabled much of the costimulatory machinery (64, 65), Ag triggering of T cells will lead to skewing of the immune response by default to a Th2 type. In conclusion, this study provides a paradigm to further investigate how PI3'-K regulates caspase-8 activation, and also to examine whether preferential Fas-mediated apoptosis of Th1 cells is an additional modality for immune deviation.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Padmini Salgame, Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140. E-mail address:
3 Abbreviations used in this paper: FasL, Fas ligand; DISC, death-inducing signaling complex; PI3'-K, phosphatidylinositol 3'-kinase; WT, wild-type; FADD, Fas-associated death domain protein; ICE, IL-1ß-converting enzyme; FLICE, FADD-like ICE; c-FLIP, cellular FLICE-inhibiting protein; LAT, linker for activation of T cells.
Received for publication June 9, 1999. Accepted for publication August 16, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  L. Xue, A. Barrow, and R. Pettipher Novel Function of CRTH2 in Preventing Apoptosis of Human Th2 Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway J. Immunol., June 15, 2009; 182(12): 7580 - 7586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sharif-Askari, D. Gaucher, R. Halwani, J. Ma, K. Jao, A. Abdallah, E. K. Haddad, and R.-P. Sekaly p56Lck Tyrosine Kinase Enhances the Assembly of Death-inducing Signaling Complex during Fas-mediated Apoptosis J. Biol. Chem., December 7, 2007; 282(49): 36048 - 36056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. C. Guillermo, E. M. Silva, F. L. Ribeiro-Gomes, J. De Meis, W. F. Pereira, H. Yagita, G. A. DosReis, and M. F. Lopes The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection J. Leukoc. Biol., April 1, 2007; 81(4): 942 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murata, M. Tsuboi, K. Hikita, and N. Kaneda Protective Effects of Neurotrophic Factors on Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis of Murine Adrenal Chromaffin Cell Line tsAM5D J. Biol. Chem., August 11, 2006; 281(32): 22503 - 22516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. L. Tamma, K. W. Chung, T. Patel, S. P. Balan, and S. Pahwa p38 MAPK plays a role in IL-4 synthesis in jacalin plus CD28-stimulated CD4+ T cells--II J. Leukoc. Biol., June 1, 2006; 79(6): 1339 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tong, H. S. Bandulwala, B. S. Clay, R. A. Anders, R. A. Shilling, D. D. Balachandran, B. Chen, J. V. Weinstock, J. Solway, K. J. Hamann, et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma J. Exp. Med., May 15, 2006; 203(5): 1173 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cudrici, F. Niculescu, T. Jensen, E. Zafranskaia, M. Fosbrink, V. Rus, M. L. Shin, and H. Rus C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP. J. Immunol., March 1, 2006; 176(5): 3173 - 3180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Beier, J. Wischhusen, M. Gleichmann, E. Gerhardt, A. Pekanovic, A. Krueger, V. Taylor, U. Suter, P. H. Krammer, M. Endres, et al. FasL (CD95L/APO-1L) Resistance of Neurons Mediated by Phosphatidylinositol 3-Kinase-Akt/Protein Kinase B-Dependent Expression of Lifeguard/Neuronal Membrane Protein 35 J. Neurosci., July 20, 2005; 25(29): 6765 - 6774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, Y. Wang, J. Zhang, H. P. Kim, S. W. Ryter, and A. M. K. Choi FLIP Protects against Hypoxia/Reoxygenation-Induced Endothelial Cell Apoptosis by Inhibiting Bax Activation Mol. Cell. Biol., June 1, 2005; 25(11): 4742 - 4751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Tseveleki, J. Bauer, E. Taoufik, C. Ruan, L. Leondiadis, S. Haralambous, H. Lassmann, and L. Probert Cellular FLIP (Long Isoform) Overexpression in T Cells Drives Th2 Effector Responses and Promotes Immunoregulation in Experimental Autoimmune Encephalomyelitis J. Immunol., December 1, 2004; 173(11): 6619 - 6626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shah and P. W. Sylvester Tocotrienol-Induced Caspase-8 Activation Is Unrelated to Death Receptor Apoptotic Signaling in Neoplastic Mammary Epithelial Cells Experimental Biology and Medicine, September 1, 2004; 229(8): 745 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gnesutta and A. Minden Death Receptor-Induced Activation of Initiator Caspase 8 Is Antagonized by Serine/Threonine Kinase PAK4 Mol. Cell. Biol., November 1, 2003; 23(21): 7838 - 7848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Taylor, C. Gercel-Taylor, K. S. Lyons, J. Stanson, and T. L. Whiteside T-Cell Apoptosis and Suppression of T-Cell Receptor/CD3-{zeta} by Fas Ligand-Containing Membrane Vesicles Shed from Ovarian Tumors Clin. Cancer Res., November 1, 2003; 9(14): 5113 - 5119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Strauss, I. Knape, I. Melzner, and K.-M. Debatin Constitutive Caspase Activation and Impaired Death-Inducing Signaling Complex Formation in CD95-Resistant, Long-Term Activated, Antigen-Specific T Cells J. Immunol., August 1, 2003; 171(3): 1172 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. AKDIS, A. TRAUTMANN, S. KLUNKER, I. DAIGLE, U. C. KUCUKSEZER, W. DEGLMANN, R. DISCH, K. BLASER, and C. A. AKDIS T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells FASEB J, June 1, 2003; 17(9): 1026 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Engedal and H. K. Blomhoff Combined Action of ERK and NFkappa B Mediates the Protective Effect of Phorbol Ester on Fas-induced Apoptosis in Jurkat Cells J. Biol. Chem., March 21, 2003; 278(13): 10934 - 10941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Ohman, L Franzen, U Rudolph, L Birnbaumer, and E H. Hornquist Regression of Peyer's patches in G{alpha}i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis Gut, September 1, 2002; 51(3): 392 - 397. [Abstract] [Full Text]
|
|
|
|
|
|
R. G. Jones, A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W.-C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly J. Exp. Med., August 5, 2002; 196(3): 335 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. W. Meng, M. P. Heldebrant, and S. H. Kaufmann Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death Domain J. Biol. Chem., January 25, 2002; 277(5): 3776 - 3783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yoshida, T. Watanabe, T. Usui, Y. Matsunaga, Y. Shirai, M. Yamori, T. Itoh, S. Habu, T. Chiba, T. Kita, et al. CD4 T cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to BALB/c and SCID mice Int. Immunol., December 1, 2001; 13(12): 1561 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wipasa, H. Xu, A. Stowers, and M. F. Good Apoptotic Deletion of Th Cells Specific for the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein 1 During Malaria Infection J. Immunol., October 1, 2001; 167(7): 3903 - 3909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Varadhachary, M. Edidin, A. M. Hanlon, M. E. Peter, P. H. Krammer, and P. Salgame Phosphatidylinositol 3'-Kinase Blocks CD95 Aggregation and Caspase-8 Cleavage at the Death-Inducing Signaling Complex by Modulating Lateral Diffusion of CD95 J. Immunol., June 1, 2001; 166(11): 6564 - 6569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roozendaal, E. Vellenga, M. A. de Jong, K. F. Traanberg, D. S. Postma, J. G. R. de Monchy, and H. F. Kauffman Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by {{gamma}}-glutamyltranspeptidase Int. Immunol., April 1, 2001; 13(4): 519 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kirchhoff, W. W. Muller, A. Krueger, I. Schmitz, and P. H. Krammer TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity J. Immunol., December 1, 2000; 165(11): 6293 - 6300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Gibbons and M. J. Pollman Death Receptors, Intimal Disease, and Gene Therapy : Are Therapies That Modify Cell Fate Moving too Fas? Circ. Res., May 26, 2000; 86(10): 1009 - 1012. [Full Text] [PDF]
|
|
|
|
|
|
M. Gomez-Angelats, C. D. Bortner, and J. A. Cidlowski Protein Kinase C (PKC) Inhibits Fas Receptor-induced Apoptosis through Modulation of the Loss of K+ and Cell Shrinkage. A ROLE FOR PKC UPSTREAM OF CASPASES J. Biol. Chem., June 23, 2000; 275(26): 19609 - 19619. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
